Log in to save to my catalogue

Avidity in antibody effector functions and biotherapeutic drug design

Avidity in antibody effector functions and biotherapeutic drug design

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9255845

Avidity in antibody effector functions and biotherapeutic drug design

About this item

Full title

Avidity in antibody effector functions and biotherapeutic drug design

Publisher

London: Nature Publishing Group UK

Journal title

Nature reviews. Drug discovery, 2022-10, Vol.21 (10), p.715-735

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Antibodies are the cardinal effector molecules of the immune system and are being leveraged with enormous success as biotherapeutic drugs. A key part of the adaptive immune response is the production of an epitope-diverse, polyclonal antibody mixture that is capable of neutralizing invading pathogens or disease-causing molecules through binding int...

Alternative Titles

Full title

Avidity in antibody effector functions and biotherapeutic drug design

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9255845

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9255845

Other Identifiers

ISSN

1474-1776

E-ISSN

1474-1784

DOI

10.1038/s41573-022-00501-8

How to access this item